Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in mice

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 3, 2003, Pages 280-291

  Mori, Takashi ^a   Kobayashi, Mariko ^b   Town, Terrence ^a   Fujita, Shinobu C ^b   Asano, Takao ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

Author keywords

Apolipoprotein E; Focal cerebral ischemia; Knock in mouse

Indexed keywords

APOLIPOPROTEIN E4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; DISEASE PREDISPOSITION; EMBRYO; GENE LOCUS; GENOTYPE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KNOCKIN MOUSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037339577     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.3.280     Document Type: Article

References (45)

1. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30
2. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30
3. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 1985;82:203-7
4. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985;76:1501-13
5. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-23
7. Strittmatter WJ, Saunders AM. Schmechel D, et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977-81
8. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995;346:575
9. Nicoll JA, Roberts GW, Graham DI. Apolipoprolein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nat Med 1995;1:135-37
10. Roses AD, Saunders A. Head injury, amyloid β and Alzheimer's disease. Nat Med 1995;1:603-4
11. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069-71
12. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. JAMA 1997;278:136-40
13. Kokubo Y, Chowdhury AH, Date C, Yokoyama T. Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000;31:1299-306
14. Leung CH, Poon WS, Yu LM, Wong GK, Ng HK. Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 2002;33:548-52
15. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology 1999;53:1308-11
16. Sheng H, Laskowitz DT, Bennett E, et al. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 1998;18:361-66
17. Buttini M, Orth M, Bellosta S. et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: Isoform-specific effects on neurodegeneration. J Neurosci 1999;19:4867-80
18. Buttini M, Akeefe H, Lin C, et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 2000;97:207-10
19. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 1999;73:2613-16
20. Horsburgh K, McCulloch J, Nilsen M, Roses AD, Nicoll JA. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur J Neurosci 2000;12:4309-17
21. White F, Nicoll JA, Roses AD, Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of en?orhinal cortex lesion. Neurobiol Dis 2001;8:611-25
22. Michikawa M, Fan QW, Isobe I, Yanagisawa K. Apolipoprotein E4 exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 2000;74:1008-16
23. LaDu MJ, Faiduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-6
24. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-52
25. Holtzman DM, Pitas RE, Kilbridge J, et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci U S A 1995;92:9480-84
26. Hamanaka H, Katoh-Fukui Y, Suzuki K, et al. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum Mol Genet 2000;9:353-61
27. Green EK, Bain SC, Day PJ, et al. Detection of human apolipoprotein E3, E2, and E4 genotypes by an allele-specific oligonucleotide-primed polymerase chain reaction assay: Development and validation. Clin Chem 1991;37:1263-68
28. Planel E, Yasutake K, Fujita SC, Ishiguro K. Inhibition of protein phosphatase 2A overrides tau protein kinase 1/glycogen synthase kinase 3β and cyctin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 2001;276:34298-306
29. Fujita SC, Sakuta K, Tsuchiya R, Hamanaka H. Apolipoprotein E is found in astrocytes but not microglia in the normal mouse brain. Neurosci Res 1999;35:123-33
30. Morikawa E, Mori H, Kiyama Y, Mishina M, Asano T, Kirino T. Attenuation of focal ischemic brain injury in mice deficient in the ε1 (NR2A) subunit of NMDA receptor. J Neurosci 1998;18:9727-32
31. Mori T, Asano T, Matsui T, et al. Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res 1999;816:350-57
32. Mori T, Muramatsu H, Matsui T, McKee A, Asano T. Possible role of the superoxide anion in the development of neuronal tolerance following ischemic preconditioning in rats. Neuropathol Appl Neurobiol 2000;26:31-40
33. Yang G, Kitagawa K. Matsushita K, et al. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: Selective neuronal death in the murine transient forebrain ischemia. Brain Res 1997;752:209-18
34. Paris D, Town T, Parker TA, Humphrey J, Mullan M. Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's β-amyloid peptide. Neurosci Lett 1998;256:73-76
35. Horsburgh K, McCulloch J, Nilsen M, et al. Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J Cereb Blood Flow Metab 2000;20:458-62
36. Matsui T, Mori T, Tateishi N, et al. Astrocytic activation and delayed infarct expansion following permanent focal ischemia in rats. Part I: Enhanced astrocytic synthesis of S-100β in the periinfarct area precedes the occurrence of delayed infarct expansion. J Cereb Blood Flow Metab 2002;22:711-22
37. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-65
38. Garcia JH, Liu K-F, Yoshida Y, Chen S, Lian J. Brain microvessels: Factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol 1994;145:728-40
39. Siesjö BK, Hu B, Kristiàn T. Is the cell death pathway triggered by the mitochondrion or the endoplasmic reticulum? J Cereb Blood Flow Metab 1999;19:19-26
40. Hall ED, Oostveen JA, Dunn E, Carter DB. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 1995;135:17-27
41. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B. E (LDL) receptors in the brain. J Biol Chem 1987;262:14352-60
42. Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Brain Res Rev 1998;27:119-42
43. Gong JS, Kobayashi M, Hayashi H, et al. Apolipoprotein E (apoE) isoform-dependent lipid release from astrocytes prepared from human-apoE3- and apoE4-knock-in mice. J Biol Chem 2002;277:29919-26
44. Garcia JH, Yoshida Y, Chen H, et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 1993;142:623-35
45. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999;79:1431-1568